Efficient Phase 1 Selection of CAR-T and Lymphodepletion Regimens Using Augmented Definitive Screening Design
How an augmented definitive screening design identified CAR-T and lymphodepletion regimens with 2.37-fold higher odds…
CertaraNovember 20, 2024
Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors
Find out how PopPK modelling supports precise tamibarotene dosing in pediatric and young adult solid…
CertaraNovember 14, 2024
Why clinical pharmacology & pharmacometrics should collaborate
A symbiosis between a modeler and a trialist is often required to develop a model-informed…
CertaraNovember 8, 2024
Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study
Explore how ondansetron formulations are bioequivalent under fasting and fed conditions, confirmed using Phoenix WinNonlin.
CertaraOctober 29, 2024
Why you need an integrated development plan
Learn about the Integrated Development Plan for successful drug development & its relation to the…
CertaraOctober 17, 2024
